Convergence Investment Partners LLC acquired a new position in shares of Genpact Limited (NYSE:G – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 17,019 shares of the business services provider’s stock, valued at approximately $731,000.
A number of other hedge funds also recently bought and sold shares of the company. Jensen Investment Management Inc. grew its position in Genpact by 6.4% during the 3rd quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock worth $7,449,000 after purchasing an additional 11,410 shares in the last quarter. Stifel Financial Corp purchased a new position in Genpact during the 3rd quarter valued at about $1,197,000. Blue Trust Inc. grew its stake in Genpact by 8.7% during the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock valued at $217,000 after acquiring an additional 441 shares in the last quarter. Burney Co. grew its stake in Genpact by 242.8% during the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock valued at $5,618,000 after acquiring an additional 92,641 shares in the last quarter. Finally, KBC Group NV purchased a new position in Genpact during the fourth quarter valued at approximately $298,000. 96.03% of the stock is owned by hedge funds and other institutional investors.
Genpact Stock Up 0.6 %
Shares of Genpact stock opened at $54.99 on Thursday. The stock has a market capitalization of $9.70 billion, a P/E ratio of 19.36, a PEG ratio of 1.86 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $46.63 and a two-hundred day moving average price of $42.51. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 1.24%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is currently 23.94%.
Insider Buying and Selling at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,600 shares of company stock valued at $1,538,120 in the last 90 days. 2.80% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of research analysts recently commented on G shares. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and boosted their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho boosted their price target on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Robert W. Baird boosted their target price on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Needham & Company LLC boosted their price target on Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Genpact has a consensus rating of “Hold” and an average target price of $48.44.
View Our Latest Analysis on Genpact
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- What is MarketRank™? How to Use it
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- 5 Top Rated Dividend Stocks to Consider
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What is a support level?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.